Neuburgh Advisers’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $6.8M | Buy |
107,360
+22,848
| +27% | +$1.45M | 0.21% | 96 |
|
|
2019
Q2 | $5.71M | Buy |
84,512
+15,360
| +22% | +$1.04M | 0.18% | 113 |
|
|
2019
Q1 | $4.5M | Buy |
69,152
+5,232
| +8% | +$340K | 0.15% | 128 |
|
|
2018
Q4 | $4M | Sell |
63,920
-2,624
| -4% | -$164K | 0.16% | 130 |
|
|
2018
Q3 | $5.14M | Sell |
66,544
-160,800
| -71% | -$12.4M | 0.17% | 127 |
|
|
2018
Q2 | $16.1M | Sell |
227,344
-1,904
| -0.8% | -$135K | 0.54% | 46 |
|
|
2018
Q1 | $17.3M | Buy |
229,248
+51,328
| +29% | +$3.87M | 0.6% | 44 |
|
|
2017
Q4 | $12.7M | Sell |
177,920
-4,144
| -2% | -$297K | 0.46% | 56 |
|
|
2017
Q3 | $14.8M | Sell |
182,064
-19,632
| -10% | -$1.59M | 0.55% | 47 |
|
|
2017
Q2 | $14.3M | Sell |
201,696
-84,160
| -29% | -$5.96M | 0.54% | 48 |
|
|
2017
Q1 | $19.4M | Sell |
285,856
-219,648
| -43% | -$14.9M | 0.77% | 34 |
|
|
2016
Q4 | $36.2M | Buy |
+505,504
| New | +$36.2M | 1.63% | 12 |
|